{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T08:39:05Z","timestamp":1792744745133,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejmech.2021.113789","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T11:33:06Z","timestamp":1629286386000},"page":"113789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Discovery of juglone and its derivatives as potent SARS-CoV-2 main proteinase inhibitors"],"prefix":"10.1016","volume":"225","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7164-6851","authenticated-orcid":false,"given":"Jiahua","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2409-338X","authenticated-orcid":false,"given":"Jinping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113789_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A\u00a0novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113789_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s42255-021-00347-1","article-title":"SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas","volume":"3","author":"M\u00fcller","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.ejmech.2021.113789_bib3","series-title":"Coronavirus Disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update","author":"World Health Organization","year":"2021"},{"key":"10.1016\/j.ejmech.2021.113789_bib4","first-page":"45","article-title":"A\u00a0review of the safety of favipiravir\u2013a potential treatment in the COVID-19 pandemic?","volume":"6","author":"Pilkington","year":"2020","journal-title":"J.\u00a0Virus Erad."},{"key":"10.1016\/j.ejmech.2021.113789_bib5","first-page":"465","article-title":"Lopinavir\u2013ritonavir in severe COVID-19","volume":"26","author":"Stower","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2021.113789_bib6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/jac\/dkaa403","article-title":"Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis","volume":"76","author":"Kashour","year":"2021","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2021.113789_bib7","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of covid-19 \u2014 final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113789_bib9","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/cid\/ciaa321","article-title":"Could chloroquine\/hydroxychloroquine be harmful in coronavirus disease 2019 (COVID-19) treatment?","volume":"71","author":"Guastalegname","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113789_bib10","doi-asserted-by":"crossref","first-page":"m2263","DOI":"10.1136\/bmj.m2263","article-title":"Covid-19: hydroxychloroquine does not benefit hospitalised patients, UK trial finds","volume":"369","author":"Torjesen","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ejmech.2021.113789_bib11","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2021.113789_bib12","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1007\/s12325-020-01351-9","article-title":"Anti COVID-19 drugs: need for more clinical evidence and global action","volume":"37","author":"Khan","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejmech.2021.113789_bib13","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.cell.2021.03.036","article-title":"SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies","volume":"184","author":"Hoffmann","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2021.113789_bib14","series-title":"Bamlanivimab Does Not Neutralize Two SARS-CoV-2 Variants Carrying E484K in\u00a0Vitro","author":"Widera","year":"2021"},{"key":"10.1016\/j.ejmech.2021.113789_bib15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41564-020-00846-z","article-title":"The SARS-CoV-2 RNA\u2013protein interactome in infected human cells","volume":"6","author":"Schmidt","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ejmech.2021.113789_bib16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A\u00a0pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113789_bib17","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.abb4489","article-title":"Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113789_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113789_bib19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113789_bib20","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1021\/acsinfecdis.0c00815","article-title":"Challenges for targeting SARS-CoV-2 proteases as a therapeutic strategy for COVID-19","volume":"7","author":"Steuten","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113789_bib21","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.2174\/0929867327999200917150939","article-title":"Natural COX-2 inhibitors as promising anti-inflammatory agents: an update","volume":"28","author":"Cui","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113789_bib22","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3389\/fphar.2020.561334","article-title":"Anti-SARS-CoV natural products with the potential to inhibit SARS-CoV-2 (COVID-19)","volume":"11","author":"Verma","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113789_bib23","doi-asserted-by":"crossref","first-page":"19790","DOI":"10.1039\/D0RA04199H","article-title":"Nature as a treasure trove of potential anti-SARS-CoV drug leads: a structural\/mechanistic rationale","volume":"10","author":"Sayed","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2021.113789_bib24","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/0006-2952(86)90157-7","article-title":"Mechanisms of toxicity of naphthoquinones to isolated hepatocytes","volume":"35","author":"Miller","year":"1986","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113789_bib25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/(SICI)1521-3773(19990201)38:3<270::AID-ANIE270>3.0.CO;2-0","article-title":"The chemistry and biology of alkannin, shikonin, and related naphthazarin natural products","volume":"38","author":"Papageorgiou","year":"1999","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2021.113789_bib26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1126\/science.877572","article-title":"Bioactivation as a model for drug design bioreductive alkylation","volume":"197","author":"Moore","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113789_bib27","first-page":"273","article-title":"In\u00a0vitro stimulation of human granulocytes and lymphocytes by pico-and femtogram quantities of cytostatic agents","volume":"38","author":"Wagner","year":"1988","journal-title":"Arzneim. Forsch."},{"key":"10.1016\/j.ejmech.2021.113789_bib28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.cbi.2010.01.041","article-title":"Cytotoxic activity of naphthoquinones with special emphasis on juglone and its 5-O-methyl derivative","volume":"184","author":"Montenegro","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2021.113789_bib29","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1021\/ed050p782","article-title":"Juglone and allelopathy","volume":"50","author":"Soderquist","year":"1973","journal-title":"J.\u00a0Chem. Educ."},{"key":"10.1016\/j.ejmech.2021.113789_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-3565(25)04514-8","article-title":"Toxicity of menadione, menadiol and esters","volume":"75","author":"Ansbacher","year":"1942","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2021.113789_bib31","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1136\/bmj.2.4120.1220","article-title":"A\u00a0vitamin K analogue in obstructive jaundice","volume":"2","author":"Macfie","year":"1939","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ejmech.2021.113789_bib32","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1021\/ja01190a003","article-title":"Naphthoquinone antimalarials. III. Diene synthesis of 1, 4-naphthoquinones","volume":"70","author":"Fieser","year":"1948","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113789_bib33","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/jccs.201300065","article-title":"An efficient synthesis of 5,6-dimethoxy 1- and 2-naphthols via Teuber reaction","volume":"60","author":"Cui","year":"2013","journal-title":"J.\u00a0Chin. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113789_bib34","first-page":"553","article-title":"An efficient multigram synthesis of juglone methyl ether","volume":"39","author":"Cui","year":"2015","journal-title":"J.\u00a0Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113789_bib35","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1080\/00397911.2016.1199807","article-title":"Synthesis of 4,8-dimethoxy-1-naphthol via an acetyl migration","volume":"47","author":"Zhang","year":"2017","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2021.113789_bib36","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1021\/acs.jmedchem.5b00265","article-title":"Design and synthesis of new \u03b1-naphthoflavones as cytochrome P450 (CYP) 1B1 inhibitors to overcome docetaxel-resistance associated with CYP1B1 overexpression","volume":"58","author":"Cui","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113789_bib37","article-title":"A\u00a0regioselective synthesis of 7-methyl juglone and its derivatives","author":"Cui","year":"2020","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2021.113789_bib38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ardp.19883210312","article-title":"Eine neue plumbagin-synthese","volume":"321","author":"M\u00f6hrle","year":"1988","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2021.113789_bib39","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1021\/jm00087a014","article-title":"Novel anthraquinone inhibitors of human leukocyte elastase and cathepsin G,","volume":"35","author":"Zembower","year":"1992","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113789_bib40","doi-asserted-by":"crossref","first-page":"7906","DOI":"10.1021\/jo00079a042","article-title":"Preparation of functionalized juglone acetates and juglones via 1,4-dimethoxynaphthalene derivatives: synthesis of anthraquinones related to rhein and aloe-emodin","volume":"58","author":"Bloomer","year":"1993","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113789_bib41","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.bbrc.2019.05.148","article-title":"Structure-based discovery of antiviral inhibitors targeting the E dimer interface of Japanese encephalitis virus","volume":"515","author":"Ye","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113789_bib42","first-page":"1","article-title":"A\u00a0summary of extraction, properties, and potential uses of juglone: a literature review","volume":"13","author":"Strugstad","year":"2012","journal-title":"J.\u00a0Ecosyst. Manage."},{"key":"10.1016\/j.ejmech.2021.113789_bib43","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.cellbi.2009.06.018","article-title":"Juglone, a naphthoquinone from walnut, exerts cytotoxic and genotoxic effects against cultured melanoma tumor cells","volume":"33","author":"Aithal","year":"2009","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.ejmech.2021.113789_bib44","first-page":"41","volume":"44","author":"Husson","year":"1986","journal-title":"Ann. Pharm. Fr."},{"key":"10.1016\/j.ejmech.2021.113789_bib45","first-page":"3473","article-title":"Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation","volume":"119","author":"Yang","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ejmech.2021.113789_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027228","article-title":"Profiling of substrate specificities of 3C-like proteases from group 1, 2a, 2b, and 3 coronaviruses","volume":"6","author":"Chuck","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2021.113789_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240653","article-title":"Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: a molecular docking and simulation studies","volume":"15","author":"Cherrak","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2021.113789_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2020.1760136","article-title":"Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach","author":"Enmozhi","year":"2020","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2021.113789_bib49","doi-asserted-by":"crossref","first-page":"109309","DOI":"10.1016\/j.cbi.2020.109309","article-title":"In silico analysis of selected alkaloids against main protease (Mpro) of SARS-CoV-2","volume":"332","author":"Garg","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2021.113789_bib50","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41586-020-2787-6","article-title":"Animal models for COVID-19","volume":"586","author":"Mu\u00f1oz-Fontela","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113789_bib51","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.tips.2020.05.005","article-title":"In\u00a0vitro and animal models for SARS-CoV-2 research","volume":"41","author":"Takayama","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2021.113789_bib52","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-020-2423-5","article-title":"Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2","volume":"585","author":"Williamson","year":"2020","journal-title":"Nature"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421006383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421006383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:32:33Z","timestamp":1759329153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421006383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":51,"alternative-id":["S0223523421006383"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113789","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of juglone and its derivatives as potent SARS-CoV-2 main proteinase inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113789","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113789"}}